Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Unknown × Hyperaldosteronism × Clear all

Phase

Phase NA 1 Phase 4 1

Status

Unknown 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 45 Neoplasms 35 Carcinoma, Hepatocellular 35 Colorectal Neoplasms 23 Polycystic Ovary Syndrome 22 Stomach Neoplasms 18 Carcinoma, Non-Small-Cell Lung 15 Prostatic Neoplasms 14 Precursor Cell Lymphoblastic Leukemia-Lymphoma 14 Pancreatic Neoplasms 12 Recurrence 11 Lymphoma 11 Liver Neoplasms 11 Leukemia, Myeloid, Acute 11 Esophageal Neoplasms 9 Colonic Neoplasms 9 Urinary Bladder Neoplasms 8 Pain 8 Lung Neoplasms 8 Leiomyoma 8 Uterine Cervical Neoplasms 6 Pain, Postoperative 6 Neoplasm Metastasis 6 Multiple Myeloma 6 Lymphoma, Follicular 6 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 6 Keratosis, Actinic 6 Infertility 6 Neutropenia 5 NSCLC 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02127840 2014-05-01

ISIRA

Charles University, Czech Republic

Phase 4 Unknown

ACTH Syndrome, Ectopic, Hyperaldosteronism, Hypertension

Data powered by HemOnc (CC BY 4.0) Colophon ⚡